IP Verse

Novel Lipid Formulations For Nucleic Acid Delivery - EP2279254B1

PatentPatent Analysis

EP2279254

ARBUTUS BIOPHARMA
Application Number
EP09731866A
Filing Date
Apr 15, 2009
Status
Granted And Under Opposition
Jun 2, 2017
Grant Date
Jul 5, 2017
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP4241767B1

Bibliography

The patent EP2279254B1 was granted to Arbutus Biopharma on Jul 5, 2017 following the initial filing on Apr 15, 2009 under the application number EP09731866A . The current legal status of the patent is Granted And Under Opposition.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

MERCK SHARP & DOHMEApr 5, 2018ADMISSIBLE
MODERNATXApr 5, 2018ADMISSIBLE

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents